BEGIN:VCALENDAR VERSION:2.0 PRODID:IEEE vTools.Events//EN CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT DTSTART:20240310T030000 TZOFFSETFROM:-0800 TZOFFSETTO:-0700 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZNAME:PDT END:DAYLIGHT BEGIN:STANDARD DTSTART:20231105T010000 TZOFFSETFROM:-0700 TZOFFSETTO:-0800 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZNAME:PST END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTAMP:20241130T231927Z UID:E6D794B9-3514-4478-B1BF-7BEAA4A5E819 DTSTART;TZID=America/Los_Angeles:20240222T113000 DTEND;TZID=America/Los_Angeles:20240222T131500 DESCRIPTION:Nanomaterial-Based Neural Implants with Stem Cells for the Trea tment of Stroke\n\nConductiveBio is developing advanced therapeutics for t he treatment of stroke\, the leading cause of death and disability worldwi de.\n\n________________________________\n\nNanomaterial-Based Neural Impla nts Combining Stem Cell Delivery with Electrical Stimulation for the Treat ment of Stroke\nDr. Michael Spaid\, Founder and CEO\, ConductiveBio Inc.\n \nIn-Person Meeting. Register: [Here](https://ieee.us6.list-manage.com/tra ck/click?u=4f23d76911d28dcc51bf71bce&id=402af34b1f&e=64f32f76c7)\n\nThurs Feb 22\n11:30am: Networking & Pizza\nNoon-1PM: Seminar\nCost: $4 to $6\nLo cation: EAG Laboratories - 810 Kifer Road\, Sunnyvale\n==> Use corner entr ance: Kifer Road / San Lucar Court\n==> Do not enter at main entrance on K ifer Road\n\nConductiveBio is developing advanced therapeutics for the tre atment of stroke\, the leading cause of death and disability worldwide. Cu rrently\, medical interventions for stroke are limited to within the first 24 hours\, leaving many patients without viable treatment options. Our in novative stroke therapy approach combines stem cell transplantation with e lectrical stimulation\, opening the possibility of extended treatment wind ows beyond the current 24-hour limitation.\nStem cells are delivered near the stroke center on a nanomaterial-based conductive bioscaffold that enab les in-vivo electrical stimulation\, and provides an ideal neural environm ent for cell growth and proliferation. ConductiveBio’s bioscaffolding pl atform integrates a mesh of metal nanowires with a tissue-mimicking nanost ructured biopolymer on flexible and transparent support. Stem cells seeded on the bioscaffold attach to the biopolymer and are electrically stimulat ed\, inducing the production of key cell signaling and neurotrophic factor s that promote healing.\nConductiveBio has designed an in-vitro bioscaffol ding platform tailored to identify and optimize cell stimulation condition s. The design\, structure\, and properties of this platform will be discus sed in detail.\n\nRead more:\n[Electrical modulation of transplanted stem cells improves functional recovery in a rodent model of stroke](https://ie ee.us6.list-manage.com/track/click?u=4f23d76911d28dcc51bf71bce&id=aa9a718d a4&e=64f32f76c7)\n[Mini review of synthesis strategies of silver nanowires and their applications](https://ieee.us6.list-manage.com/track/click?u=4f 23d76911d28dcc51bf71bce&id=b5c26b83dd&e=64f32f76c7)\n\nMichael Spaid\, Ph. D.\, is the founder and CEO of ConductiveBio Incorporated\, an early-stage start-up focused on developing novel combination medical devices for the treatment of stroke. ConductiveBio’s flexible circuit technology was in- licensed from his previous company Cambrios where he served as CTO. Cambri os commercialized the world’s first transparent conductor based on silve r nanowires\, now ubiquitous in smart phones\, tablets\, and large-area di splays for touch sensing applications.\nPrior to his venture at Cambrios\, Michael served as the Director of Microfluidics Engineering at Caliper Li fe Sciences\, managing the team responsible for conceiving and designing t he company’s microfluidic chips. His professional journey also includes a stint as a project engineer at Corning\, Inc. and as an NRC Postdoctoral Fellow at the National Institute of Standards and Technology where he dev eloped modeling techniques for simulating complex multi-component immiscib le flows using the Lattice Boltzmann Method. He received his BS from Tulan e University\, and his MS and Ph.D. degrees from Stanford University in ch emical engineering.\n\nBldg: Use corner entrance: Kifer Rd. / San Lucar Ct .=> Do use main entrance on Kifer Rd.\,\, EAG Laboratories\, 810 Kifer Roa d\, Sunnyvale\, California\, United States\, 94086 LOCATION:Bldg: Use corner entrance: Kifer Rd. / San Lucar Ct.=> Do use main entrance on Kifer Rd.\,\, EAG Laboratories\, 810 Kifer Road\, Sunnyvale\, California\, United States\, 94086 ORGANIZER:g.m.friedman@ieee.org SEQUENCE:9 SUMMARY:Nanomaterial-Based Implants with Stem Cells for the Treatment of St roke URL;VALUE=URI:https://events.vtools.ieee.org/m/406496 X-ALT-DESC:Description: <br /><p>&nbsp\;</p>\n<blockquote><center>\n<table id="yiv5411425140m_-4718462214600896958bodyTable" border="0" width="100%" cellspacing="0" cellpadding="0" align="center">\n<tbody>\n<tr>\n<td id="yi v5411425140m_-4718462214600896958bodyCell" align="left" valign="top">\n<ta ble border="0" width="100%" cellspacing="0" cellpadding="0">\n<tbody>\n<tr >\n<td id="yiv5411425140m_-4718462214600896958templateBody" valign="top">\ n<table border="0" width="100%" cellspacing="0" cellpadding="0">\n<tbody>\ n<tr>\n<td valign="top">\n<table border="0" width="100%" cellspacing="0" c ellpadding="0" align="left">\n<tbody>\n<tr>\n<td valign="top">\n<table bor der="0" width="100%" cellspacing="0" cellpadding="0">\n<tbody>\n<tr>\n<td> \n<table border="0" width="100%" cellspacing="0" cellpadding="0" align="le ft">\n<tbody>\n<tr>\n<td>\n<h4>Nanomaterial-Based Neural Implants with Ste m Cells for the Treatment of Stroke</h4>\n<p><em><strong>ConductiveBio is developing advanced therapeutics for the treatment of stroke\, the leading cause of death and disability worldwide.</strong></em></p>\n<p>__________ ______________________</p>\n<blockquote><center>\n<table id="yiv5411425140 m_-4718462214600896958bodyTable" border="0" width="100%" cellspacing="0" c ellpadding="0" align="center">\n<tbody>\n<tr>\n<td id="yiv5411425140m_-471 8462214600896958bodyCell" align="left" valign="top">\n<table border="0" wi dth="100%" cellspacing="0" cellpadding="0">\n<tbody>\n<tr>\n<td id="yiv541 1425140m_-4718462214600896958templateBody" valign="top">\n<table border="0 " width="100%" cellspacing="0" cellpadding="0">\n<tbody>\n<tr>\n<td valign ="top">\n<table border="0" width="100%" cellspacing="0" cellpadding="0" al ign="left">\n<tbody>\n<tr>\n<td valign="top">\n<table border="0" width="10 0%" cellspacing="0" cellpadding="0">\n<tbody>\n<tr>\n<td>\n<table border=" 0" width="100%" cellspacing="0" cellpadding="0" align="left">\n<tbody>\n<t r>\n<td>\n<h4>Nanomaterial-Based Neural Implants Combining Stem Cell Deliv ery with Electrical Stimulation for the Treatment of Stroke<br />Dr. Micha el Spaid\, Founder and CEO\, ConductiveBio Inc.</h4>\n<p><span id="yiv5411 425140m_-4718462214600896958e-ct"><strong>In-Person Meeting</strong></span ><strong>. Register:&nbsp\;<a href="https://ieee.us6.list-manage.com/track /click?u=4f23d76911d28dcc51bf71bce&amp\;id=402af34b1f&amp\;e=64f32f76c7" t arget="_blank" rel="nofollow noopener noreferrer">Here</a></strong><br />& nbsp\;<br /><strong>Thurs Feb 22</strong><br />11:30am: Networking &amp\; Pizza<br />&nbsp\;&nbsp\;&nbsp\;&nbsp\; Noon-1PM: Seminar<br />&nbsp\;&nbs p\;&nbsp\;&nbsp\; Cost: $4 to $6<br /><strong>Location: EAG Laboratories - 810 Kifer Road\, Sunnyvale</strong><br /><em>&nbsp\;&nbsp\;&nbsp\;&nbsp\; &nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbs p\; ==&gt\; Use corner entrance: Kifer Road / San Lucar Court<br />&nbsp\; &nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbs p\;&nbsp\;&nbsp\;&nbsp\; ==&gt\; Do not enter at main entrance on Kifer Ro ad</em></p>\n<div>&nbsp\;</div>\n&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\ ;&nbsp\;&nbsp\;<img src="https://ecp.yusercontent.com/mail?url=https%3A%2F %2Fmcusercontent.com%2F4f23d76911d28dcc51bf71bce%2Fimages%2F5a056ba3-c9fd- 07be-25a9-4b5af3edea7f.png&amp\;t=1707813326&amp\;ymreqid=d41d8cd9-8f00-b2 04-1cc8-0b0006013200&amp\;sig=4CpTT4YrOoomczq6PttD_w--~D" width="200" heig ht="240" /><br />ConductiveBio is developing advanced therapeutics for the treatment of stroke\, the leading cause of death and disability worldwide . Currently\, medical interventions for stroke are limited to within the f irst 24 hours\, leaving many patients without viable treatment options. Ou r innovative stroke therapy approach combines stem cell transplantation wi th electrical stimulation\, opening the possibility of extended treatment windows beyond the current 24-hour limitation.<br />&nbsp\;&nbsp\;&nbsp\;& nbsp\; Stem cells are delivered near the stroke center on a nanomaterial-b ased conductive bioscaffold that enables in-vivo electrical stimulation\, and provides an ideal neural environment for cell growth and proliferation . ConductiveBio&rsquo\;s bioscaffolding platform integrates a mesh of meta l nanowires with a tissue-mimicking nanostructured biopolymer on flexible and transparent support. Stem cells seeded on the bioscaffold attach to th e biopolymer and are electrically stimulated\, inducing the production of key cell signaling and neurotrophic factors that promote healing.<br />&nb sp\;&nbsp\;&nbsp\;&nbsp\; ConductiveBio has designed an in-vitro bioscaffo lding platform tailored to identify and optimize cell stimulation conditio ns. The design\, structure\, and properties of this platform will be discu ssed in detail.<br /><br /><strong>Read more:</strong><br /><a href="https ://ieee.us6.list-manage.com/track/click?u=4f23d76911d28dcc51bf71bce&amp\;i d=aa9a718da4&amp\;e=64f32f76c7" target="_blank" rel="nofollow noopener nor eferrer">Electrical modulation of transplanted stem cells improves functio nal recovery in a rodent model of stroke</a><br /><a href="https://ieee.us 6.list-manage.com/track/click?u=4f23d76911d28dcc51bf71bce&amp\;id=b5c26b83 dd&amp\;e=64f32f76c7" target="_blank" rel="nofollow noopener noreferrer">M ini review of synthesis strategies of silver nanowires and their applicati ons</a><br /><br />&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;<img src="htt ps://ecp.yusercontent.com/mail?url=https%3A%2F%2Fmcusercontent.com%2F4f23d 76911d28dcc51bf71bce%2Fimages%2F5cb8a59b-7afe-2a9b-51d8-54d22ecab206.png&a mp\;t=1707813326&amp\;ymreqid=d41d8cd9-8f00-b204-1cc8-0b0006013200&amp\;si g=ZOZYhqUHqQU31SBT7pOmIQ--~D" width="200" height="257" /><br /><strong>Mic hael Spaid\, Ph.D.\,&nbsp\;</strong>is the founder and CEO of ConductiveBi o Incorporated\, an early-stage start-up focused on developing novel combi nation medical devices for the treatment of stroke. ConductiveBio&rsquo\;s flexible circuit technology was in-licensed from his previous company Cam brios where he served as CTO. Cambrios commercialized the world&rsquo\;s f irst transparent conductor based on silver nanowires\, now ubiquitous in s mart phones\, tablets\, and large-area displays for touch sensing applicat ions.<br />&nbsp\;&nbsp\;&nbsp\;&nbsp\; Prior to his venture at Cambrios\, Michael served as the Director of Microfluidics Engineering at Caliper Li fe Sciences\, managing the team responsible for conceiving and designing t he company&rsquo\;s microfluidic chips. His professional journey also incl udes a stint as a project engineer at Corning\, Inc. and as an NRC Postdoc toral Fellow at the National Institute of Standards and Technology where h e developed modeling techniques for simulating complex multi-component imm iscible flows using the Lattice Boltzmann Method.&nbsp\; He received his B S from Tulane University\, and his MS and Ph.D. degrees from Stanford Univ ersity in chemical engineering.</td>\n</tr>\n</tbody>\n</table>\n</td>\n</ tr>\n</tbody>\n</table>\n</td>\n</tr>\n</tbody>\n</table>\n</td>\n</tr>\n< /tbody>\n</table>\n</td>\n</tr>\n</tbody>\n</table>\n</td>\n</tr>\n</tbody >\n</table>\n</center></blockquote>\n</td>\n</tr>\n</tbody>\n</table>\n</t d>\n</tr>\n</tbody>\n</table>\n</td>\n</tr>\n</tbody>\n</table>\n</td>\n</ tr>\n</tbody>\n</table>\n</td>\n</tr>\n</tbody>\n</table>\n</td>\n</tr>\n< /tbody>\n</table>\n</center></blockquote> END:VEVENT END:VCALENDAR